Late treatment study
et al., medRxiv, doi:10.1101/2020.11.16.20232223 (Preprint)
Clinical Profile of First 1000 COVID-19 Cases Admitted at Tertiary Care Hospitals and the Correlates of their Mortality: An Indian Experience
Retrospective 976 hospitalized patients with 834 treated with HC
Q+AZ showing HC
Q mortality relative risk RR 0.35, p
< 0.0001. Note that in this case HC
Q was recommended for mild/moderate cases, so more severe cases may not have received HC
Q (which may also be why they became severe cases). We note that this is opposite to a common bias in HC
Q studies - in many cases HC
Q was more likely to be given to more severe cases.
death, ↓65.4%, p<0.0001
Please send us corrections, updates, or comments.